Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Monocytic Tlr4 Expression and Activation in Schizophrenia: A Systematic Review and Meta-Analysis Publisher Pubmed

Summary: Schizophrenia clue? Study finds trend of higher TLR4 density in monocytes—no gene expression difference. Suggests immune role. #Schizophrenia #Immunology

Jameie M1, 2 ; Bordbar S3, 4 ; Samiee R2, 5 ; Amanollahi M5, 6 ; Azizmohammad Looha M7 ; Aleyasin MS3 ; Homayuni MRA5, 8 ; Mozafar M5 ; Jameie SB1 ; Akhondzadeh S9
Authors

Source: PLoS ONE Published:2025


Abstract

Background The role of toll-like receptor 4 (TLR4) in schizophrenia remains unclear, with studies reporting conflicting results on its expression and activation in persons with schizophrenia (PwSCZ). This systematic review/meta-analysis compared basal monocytic TLR4 expression, as well as its activation pattern between PwSCZ and healthy controls (HCs). Methods This study was registered with PROSPERO (CRD42021273858) and adhered to the PRISMA guidelines. A systematic search was conducted through MEDLINE (via PubMed), Web of Science, and Scopus from inception to December 12, 2023. Quantitative syntheses were conducted for (a) basal monocytic TLR4 density, (b) basal percentage of TLR4+ monocytes, and (c) basal TLR4 gene expression. Effect sizes were computed using Hedges’ g for mean differences. Random-effect models with restricted maximum-likelihood estimation were used, and subgrouping was conducted based on antipsychotic status. The studies’ risk of bias was assessed using the Joanna Briggs Institute (JBI) tool. Results Eleven studies (473 PwSCZ, 416 HCs) were included. Pooled analysis revealed a nonsignificant trend toward increased basal monocytic TLR4 density in PwSCZ (Hedges’ g = 0.317 [95% CI: –0.060, 0.694], τ2 = 0.127, I2 = 68.91%). The difference became significant after sensitivity analysis and excluding one study (Hedges’ g = 0.469 [0.195,0.742], p = 0.001). No significant difference was found between the groups in terms of TLR4+ monocytes percentage (Hedges’ g = 0.235 [–0.245, 0.715], τ2 = 0.31, I2 = 87.30%) or TLR4 gene expression (Hedges’ g = 0.179 [–0.502, 0.861], τ2 = 0.29, I2 = 79.04%). According to qualitative synthesis, TLR4 stimulation resulted in reduced monocytic activation in PwSCZ compared to HCs. Conclusions This study suggested a trend toward an increased basal monocytic TLR4 density in PwSCZ, with no difference in the basal percentage of TLR4+ monocytes or TLR4 gene expression. However, the limited available data underscores the need for future studies. © 2025 Jameie et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Other Related Docs
4. Role of Toll-Like Receptor 4 in Diabetic Retinopathy, Pharmacological Research (2022)
18. Vaccines, Adjuvants, and Delivery Systems, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)
19. Herbal Medicines for Type 1 Diabetes Mellitus, Cochrane Database of Systematic Reviews (2015)